Rights and permissions
About this article
Cite this article
Antifibrinolytic offers potential savings in cardiac surgery. Pharmacoecon. Outcomes News 48, 7 (1996). https://doi.org/10.1007/BF03309944
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03309944